W.R. Grace and Co. Executives Plead Not Guilty

W.R. Grace and Co. Executives Plead Not Guilty - Asbestos & Mesothelioma News

Asbestos Today is an online magazine that aggregates the latest asbestos and mesothelioma news, since 2003.
Site Navigation
Asbestos News
Contact a Mesothelioma AttorneySpecial Report
Understanding Asbestos & MesotheliomaAsbestos facts:Asbestos exposure and risk:How can families reduce the risk of exposure to asbestos?How can asbestos affect my health?What is mesothelioma?How is mesothelioma treated?Asbestos medical testingAsbestos Related DiseasesNews Archives
September 2006
October 2005
February 2005
December 2004
November 2004
October 2004
September 2004
August 2004
July 2004
June 2004
May 2004
April 2004
March 2004
News Search

Contact Us
information [at] asbestostoday dot comW.R. Grace and Co. Executives Plead Not Guilty

Former Grace executives plead not guilty to charges that they knowingly endangering residents of Libby, Montana, and concealed information about the health affects of its asbestos mining operations.

Standing shoulder-to-shoulder, six W.R. Grace and Co. executives and their dozen-plus lawyers appeared before U.S. Magistrate Judge Leif Erickson on Tuesday to plead not guilty to charges that they knowingly concealed information about the deadly health effects of their company's vermiculite mine in Libby.

The defendants are also accused of obstructing the government's cleanup efforts and wire fraud. To date, according to the indictment, approximately 1,200 residents of Libby area have been identified as suffering from some kind of asbestos-related abnormality.

News Source: Billings Gazette  |  Published: February 28, 2005  |  Read Full Story Contact an Asbestos and Mesothelioma Attorney, Lawyer, Law Firm Please fill out the form below to contact an attorney. Provide as much information as possible to speed the processing of your inquiry (Only United States residents are eligible). Contact Information   *Are required items. *First Name: *Last Name: Email Address: *Daytime Phone: Evening Phone: *Zip Code: Case Information Have you, or the person you are contacting us on behalf of, been diagnosed with mesothelioma: Yes:   No: Date of diagnosis:

*Comments: (Please describe your legal issues and needs.)

Terms I understand submission of information submission of information for review does not create, is not intended to create, and must not be relied upon as creating, an attorney-client relationship. I understand such a relationship can only be created by the agreement of both the client and the attorney, evidenced by a written retainer agreement that has been signed by client and counter-signed by the attorney.By submitting your expression of interest you are consenting to receive telephone calls from participating law firms even if you are currently on the do-not-call list. *I Agree to these terms: All contents copyright ©2008, eJustice All rights reserved. Asbestos Today is part of the eJustice Network. Your use of this web site constitutes acceptance of the Asbestos Today Privacy Policy and Terms of Use.

View the original article here

Mesothelioma Community Will Convene to Focus on Cure

SANTA BARBARA, Calif., Sept. 22 /PRNewswire/ -- The urgent mission to improve treatments for a deadly, asbestos-related cancer will make another step forward, the Mesothelioma Applied Research Foundation (MARF) announced today, with the Second International Symposium on Malignant Mesothelioma.

Meso is a malignant tumor that aggressively invades the linings of the lungs, abdomen, heart or testicles. The need for research to develop effective treatments was neglected for decades. But in the past few years, exciting progress has begun. MARF, the national nonprofit whose mission is to eradicate meso as a life-ending disease, has organized the Symposium to review this progress, elucidate the latest advances, and strengthen and encourage the entire meso community.

The Symposium will be held in Las Vegas at the Caesars Palace convention center, October 6 through 8. Following the highly successful 2004 format, the program combines highly relevant material for the patient/family and advocacy communities with scientific presentations by leading experts on the latest in meso science and treatment.

The Symposium will open powerfully with presentations on the scope of the mesothelioma tragedy and the continuing threat, by Dr. Stephen Levin from the renowned Mount Sinai Irving Selikoff Center for Occupational and Environmental Medicine, author and Pulitzer Prize winning journalist Andrew Schneider, and international experts Michael Harbut and Michele Carbone.

Sessions focused specifically for patients and caregivers will cover the clinical aspects of the disease and its treatment, including surgery, chemotherapy, experimental treatments, and pain management. Extended break-out sessions are planned for patients, caregivers and the bereaved, to offer holistic strategies for the emotional, physical and psychological aspects of the disease.

Major scientific topics will include evolving diagnostic, prognostic and staging technologies, including the latest in early detection. Multi-modal management -- surgery, radio and chemotherapy -- will be covered in detail for both pleural and peritoneal meso. Systemic chemotherapy protocols will be reviewed, including an assessment of the Alimta/Cisplatin regimen. Second line and novel treatment approaches will be discussed, along with a thorough overview of meso research projects currently underway. Participating physicians will receive CME credits for these sessions. Patients, family members and other non-medical professionals are also welcome to attend.

News Source: PR Newswire  |  Published: October 3, 2005  |  Read Full Story

View the original article here